YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects

Phase 1

Completed

Conditions: Type II; Diabetes
Heart Failure

Interventions: Drug: Empagliflozin
Drug: Placebo Oral Capsule

First Posted Date: 2017-01-23

Last Posted Date: 2020-06-26

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT03027960

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: anetumab ravtansine

First Posted Date: 2017-01-18

Last Posted Date: 2021-10-28

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT03023722

Locations: 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Opioid Use Disorder in the Emergency Department: CTN 0069

Not Applicable

Completed

Conditions: Opioid Use Disorder

Interventions: Other: Standard Dissemination Practice
Other: Implementation Facilitation (IF)

First Posted Date: 2017-01-18

Last Posted Date: 2023-12-18

Lead Sponsor: Yale University

Target Recruit Count: 1731

Registration Number: NCT03023930

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States

and more 2 locations

Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder

Phase 2

Completed

Conditions: Social Anxiety Disorder
Performance Anxiety

Interventions: Drug: Placebo
Drug: BHV-0223

First Posted Date: 2017-01-11

Last Posted Date: 2021-05-20

Lead Sponsor: Yale University

Target Recruit Count: 22

Registration Number: NCT03017508

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Integrating HIV and Depression Self-Care to Improve Adherence in Perinatal Women

Not Applicable

Completed

Conditions: HIV Infections
Depression

Interventions: Behavioral: Attention Control Condition
Behavioral: BEST-maCARE

First Posted Date: 2017-01-10

Last Posted Date: 2020-08-17

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT03016546

Locations: 🇮🇳
Maulana Azad Medical College and Associated Lok Nayak Hospital, G.B. Pant Institute of Postgraduate Medical Education and Research Hospital and Guru Nanak Eye Center, New Delhi, India

Computer Based Training in CBT in Primary Care

Not Applicable

Completed

Conditions: Substance Abuse

Interventions: Behavioral: Standard Treatment As Usual (TAU)
Behavioral: CBT4CBT program

First Posted Date: 2017-01-06

Last Posted Date: 2018-09-12

Lead Sponsor: Yale University

Target Recruit Count: 58

Registration Number: NCT03013478

Locations: 🇺🇸
Yale New Haven Hospital St Raphael's Campus, New Haven, Connecticut, United States

Intergenerational Blood Pressure Study

Completed

Conditions: Hypertension

First Posted Date: 2017-01-06

Last Posted Date: 2020-03-20

Lead Sponsor: Yale University

Target Recruit Count: 500

Registration Number: NCT03013179

Locations: 🇺🇸
Yale University School of Nursing, Orange, Connecticut, United States

A Psychosocial Program Impact Evaluation in Jordan

Not Applicable

Completed

Conditions: Stress, Psychological
Mental Health Impairment

Interventions: Behavioral: Advancing Adolescents

First Posted Date: 2017-01-06

Last Posted Date: 2021-01-15

Lead Sponsor: Yale University

Target Recruit Count: 817

Registration Number: NCT03012451

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Fish Oil vs. Placebo on Subjective Effects of Alcohol

Phase 1

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Fish Oil with ethanol and placebo ethanol infusions
Drug: Placebo with ethanol and placebo ethanol infusions

First Posted Date: 2017-01-05

Last Posted Date: 2022-09-22

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT03010917

Locations: 🇺🇸
VA Connecticut Healtcare System, West Haven, Connecticut, United States

Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial

Phase 2

Terminated

Conditions: Deep Venous Thrombosis

Interventions: Drug: Enoxaparin

First Posted Date: 2016-12-28

Last Posted Date: 2020-07-13

Lead Sponsor: Yale University

Target Recruit Count: 51

Registration Number: NCT03003390

Locations: 🇺🇸
Saint Louis Children's Hospital-Washington University School of Medicine-, Saint Louis, Missouri, United States
🇺🇸
Maria Fareri Children's Hospital, Valhalla, New York, United States
🇺🇸
Yale University Yale New Haven Health, New Haven, Connecticut, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy